BRIEF published on 12/17/2025 at 14:43, 1 month 18 days ago First Berlin Equity Research met à jour sa recommandation sur Cardiol Therapeutics, passant à « Acheter » avec un objectif de cours abaissé. Recommandation D'achat Ajustement Du Prix Cible Thérapeutique Cardiaque Étude ARCHER De Phase II Myocardite
BRIEF published on 12/17/2025 at 14:43, 1 month 18 days ago First Berlin Equity Research Updates Cardiol Therapeutics to "Buy" with a Lowered Target Price Buy Recommendation Target Price Adjustment Cardiol Therapeutics Phase II ARCHER Study Myocarditis
PRESS RELEASE published on 12/17/2025 at 14:38, 1 month 18 days ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates BUY recommendation for Cardiol Therapeutics Inc., lowering price target to USD 7.80 based on positive Phase II ARCHER data on CardiolRx for acute myocarditis First Berlin Equity Research Buy Recommendation Acute Myocarditis Cardiol Therapeutics Inc. Phase II ARCHER Data
BRIEF published on 10/23/2025 at 12:56, 3 months 12 days ago Cardiol Therapeutics Secures Funding with USD 11.4 Million Private Placement Private Placement Clinical Trials Financial Outlook Cardiol Therapeutics Heart-Failure Therapy
BRIEF published on 10/23/2025 at 12:56, 3 months 12 days ago Cardiol Therapeutics obtient un financement avec un placement privé de 11,4 millions de dollars Placement Privé Essais Cliniques Cardiol Therapeutics Perspectives Financières Traitement De L'insuffisance Cardiaque
PRESS RELEASE published on 10/23/2025 at 12:51, 3 months 12 days ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates Cardiol Therapeutics Inc with a BUY rating and USD 8.50 price target. The private placement secures funds for pivotal trials and new product development Private Placement Cardiol Therapeutics Inc First Berlin Equity Research BUY Rating USD 8.50 Price Target
BRIEF published on 08/12/2025 at 13:36, 5 months 23 days ago Cardiol Therapeutics : résultats de l'essai de phase II et perspectives boursières positives Cardiol Therapeutics Acheter Une Note CardiolRx Essai ARCHER De Phase II Myocardite Aiguë
BRIEF published on 08/12/2025 at 13:36, 5 months 23 days ago Cardiol Therapeutics: Phase II Trial Results and Positive Stock Outlook BUY Rating Cardiol Therapeutics CardiolRx Phase II ARCHER Trial Acute Myocarditis
PRESS RELEASE published on 08/12/2025 at 13:31, 5 months 23 days ago Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY First Berlin Equity Research updates BUY recommendation for Cardiol Therapeutics Inc after positive phase II trial results for CardiolRx in acute myocarditis Cardiol Therapeutics Inc First Berlin Equity Research Phase II Trial CardiolRx Acute Myocarditis
BRIEF published on 04/23/2025 at 15:29, 9 months 11 days ago Cardiol Therapeutics Advances in Pivotal Phase III Study FDA Approval Cardiol Therapeutics Phase III Study Recurrent Pericarditis CardiolRxT
Published on 02/04/2026 at 16:15, 5 hours 6 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 15:45, 5 hours 36 minutes ago Patriot.Tv's Jd Rucker Explains Billie Eilish's Comments on ICE, Offers ICE Commentary as Exhibit A of Celebrity Sound Bite Politics
Published on 02/04/2026 at 15:00, 6 hours 21 minutes ago Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale
Published on 02/04/2026 at 20:54, 27 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 45 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 1 hour 20 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 2 hours 26 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 2 hours 40 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 3 hours 17 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 3 hours 17 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 3 hours 36 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 3 hours 36 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
